TELETRADER News
5/23, 6:19 PM (Source: TeleTrader)
more TeleTrader news

Pfizer-0.36%

52.31
Chart for: Pfizer Inc

Pfizer's jab for youngest kids 80% effective vs Omicron

Pfizer Inc. said on Monday that preliminary results determined its COVID-19 three-dose vaccine jointly developed by BioNTech SE was 80% effective against the Omicron coronavirus variant in children up to five years old.

The immune response was strong with only mild side effects, the two companies noted, adding that they were preparing to ask the Food and Drug Administration to provide the emergency use authorization for younger kids.

Meanwhile, the FDA confirmed it was reviewing the data from both Pfizer and Moderna and that it expects to approve both vaccines around the same time following its meeting set for June 15. Kids between six months and five years old receive only 10% of the dose used in adults.

Baha Breaking News (BBN) / ND